Toxoplasma GRA16 Inhibits NF-κB Activation through PP2A-B55 Upregulation in Non-Small-Cell Lung Carcinoma Cells

Nuclear factor kappa B (NF-κB) activation is a well-known mechanism by which chemoresistance to anticancer agents is reported. It is well-known that irinotecan as a chemotherapeutic drug against non-small-cell lung carcinoma (NSCLC) has limited anticancer effect due to NF-κB activation. In this stud...

Descripción completa

Detalles Bibliográficos
Autores principales: Seo, Seung-Hwan, Kim, Sang-Gyun, Shin, Ji-Hun, Ham, Do-Won, Shin, Eun-Hee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7554801/
https://www.ncbi.nlm.nih.gov/pubmed/32927892
http://dx.doi.org/10.3390/ijms21186642

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7554801/
https://www.ncbi.nlm.nih.gov/pubmed/32927892
http://dx.doi.org/10.3390/ijms21186642

Ejemplares similares